Boeravinone B

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Boeravinone B, a novel efflux pump inhibitor, apart from inhibiting the MdeA mediated efflux, also significantly inhibit the biofilm formation of S. aureus, boeravinone B may be used in combination with mupirocin for further development.

Boeravinone B, a novel efflux pump inhibitor, apart from inhibiting the MdeA mediated efflux, also significantly inhibit the biofilm formation of S. aureus, boeravinone B may be used in combination with mupirocin for further development. Boeravinone B exhibits significant anti-inflammatory activity (56.6% at 50 mg/kg) when evaluated in an in vivo carrageenan-induced rat paw model.

Boeravinone B is also active against a methicillin-resistant S. aureus (MRSA) strain, which showed a fourfold reduction in the ciprofloxacin MIC.

——

——

Others

Other Targets

——

——

——

114567-34-9

312.3

C17H12O6

>98% (HPLC)

In Vitro:?DMSO : 50 mg/mL (160.12 mM)

——

——

(-20℃)

With Ice Pack

≥ 2 years